Home

vacht Vochtig verlamming daniel den hoed cancer center Voornaamwoord Tarief Uitdrukking

Erasmus MC - Wikipedia
Erasmus MC - Wikipedia

Assessment of insertion techniques and complication rates of dual lumen  central venous catheters in patients with hematological
Assessment of insertion techniques and complication rates of dual lumen central venous catheters in patients with hematological

The Dutch Deep Hyperthermia Trial: results in cervical cancer
The Dutch Deep Hyperthermia Trial: results in cervical cancer

Daniël den Hoed – Streekarchief Eiland IJsselmonde
Daniël den Hoed – Streekarchief Eiland IJsselmonde

Nitrous oxide is not beneficial for breakthrough cancer pain
Nitrous oxide is not beneficial for breakthrough cancer pain

Alveolar Soft Part Sarcoma: Should We Be Targeting the Tumor or Targeting  the Vasculature?
Alveolar Soft Part Sarcoma: Should We Be Targeting the Tumor or Targeting the Vasculature?

Daniel den Hoedbrug - Wurck
Daniel den Hoedbrug - Wurck

Weekly low-dose mitoxantrone plus doxorubicin as second-line chemotherapy  for advanced breast cancer
Weekly low-dose mitoxantrone plus doxorubicin as second-line chemotherapy for advanced breast cancer

Heating the patient: a promising approach?
Heating the patient: a promising approach?

European Organization for Research and Treatment of Cancer (EORTC) open  label phase II study on glufosfamide administered as a 6
European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 6

Clinical introduction of Monte Carlo treatment planning: A different  prescription dose for non-small cell lung cancer according
Clinical introduction of Monte Carlo treatment planning: A different prescription dose for non-small cell lung cancer according

Nieuw Familiehuis Daniel den Hoed opent de deuren tegenover Erasmus MC -  Nieuws - Erasmus MC
Nieuw Familiehuis Daniel den Hoed opent de deuren tegenover Erasmus MC - Nieuws - Erasmus MC

Erasmus bridge and Daniel den Hoed Cancer Center
Erasmus bridge and Daniel den Hoed Cancer Center

Considerations of Healthcare Professionals in Medical Decision-Making About  Treatment for Clinical End-Stage Cancer Patients
Considerations of Healthcare Professionals in Medical Decision-Making About Treatment for Clinical End-Stage Cancer Patients

Daniel den Hoed Fonds - Erasmus MC
Daniel den Hoed Fonds - Erasmus MC

Response to adjuvant chemotherapy in primary breast cancer: no
Response to adjuvant chemotherapy in primary breast cancer: no

Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in  testicular germ cell tumour cell lines. - Abstract - Europe PMC
Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines. - Abstract - Europe PMC

Kelly Younge, Ph.DKelly Younge, Ph.D Don Roberts, Benedick Fraass, Daniel  McShan, and Martha Matuszak University of Michigan, Department of Radiation  Oncology,University. - ppt download
Kelly Younge, Ph.DKelly Younge, Ph.D Don Roberts, Benedick Fraass, Daniel McShan, and Martha Matuszak University of Michigan, Department of Radiation Oncology,University. - ppt download

Daniel den Hoed - Erasmus MC Foundation
Daniel den Hoed - Erasmus MC Foundation

Accrual Family Cancer Clinic Rotterdam (Dr Daniel den Hoed... | Download  Scientific Diagram
Accrual Family Cancer Clinic Rotterdam (Dr Daniel den Hoed... | Download Scientific Diagram

Pelvic exenteration for primary and recurrent gynaecological malignancies
Pelvic exenteration for primary and recurrent gynaecological malignancies

Surveillance with Microsatellite Analysis of Urine in Bladder Cancer  PatientsTreated by Radiotherapy
Surveillance with Microsatellite Analysis of Urine in Bladder Cancer PatientsTreated by Radiotherapy

Glycolipids of human primary testicular germ cell tumours
Glycolipids of human primary testicular germ cell tumours

EFFECTS ON FUNCTIONAL OUTCOME AFTER IORT-CONTAINING MULTIMODALITY TREATMENT  FOR LOCALLY ADVANCED PRIMARY AND LOCALLY RECURRENT R
EFFECTS ON FUNCTIONAL OUTCOME AFTER IORT-CONTAINING MULTIMODALITY TREATMENT FOR LOCALLY ADVANCED PRIMARY AND LOCALLY RECURRENT R

Stereotactic Body Radiotherapy: A Promising Treatment Option for the Boost  of Oropharyngeal Cancers Not Suitable for Brachythera
Stereotactic Body Radiotherapy: A Promising Treatment Option for the Boost of Oropharyngeal Cancers Not Suitable for Brachythera